Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

NCT05902221 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT05902221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05902221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 3
Overall status
Recruiting
Start date
May 2, 2024
Completion date
May 31, 2028
Enrollment
235 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

infections joint prosthetic